Stroke – Pipeline Review, H2 2019 :

Research By Markets adds Market Research Report - Stroke – Pipeline Review, H2 2019 :

For detailed information:

Stroke – Pipeline Review, H2 2019


Stroke – Pipeline Review, H2 2019, provides an overview of the Stroke (Cardiovascular) pipeline landscape.

Stroke is a condition in which the brain cells suddenly die because of a lack of oxygen. Symptoms occur rapidly and usually last a short time, from a few minutes to a couple of hours. The symptoms of a stroke usually appear suddenly. Initially the person may feel sick, and look pale and very unwell. They may complain of a sudden headache. They may have sudden numbness in their face or limbs, particularly down one side of their body. They may appear confused and have trouble talking or understanding what is being said to them. They may have vision problems, and trouble walking or keeping their balance.

Report Highlights

Stroke – Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Stroke (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Stroke (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Stroke and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 13, 33, 24, 1, 3, 122, 17 and 2 respectively. Similarly, the Universities portfolio in Phase III, Preclinical and Discovery stages comprises 1, 31 and 5 molecules, respectively.

Stroke (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


– The pipeline guide provides a snapshot of the global therapeutic landscape of Stroke (Cardiovascular).
– The pipeline guide reviews pipeline therapeutics for Stroke (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Stroke (Cardiovascular) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Stroke (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Stroke (Cardiovascular)

Reasons to buy

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Stroke (Cardiovascular).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Stroke (Cardiovascular) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies Mentioned:
Acorda Therapeutics Inc
Acticor Biotech SAS
Addex Therapeutics Ltd
advanceCor GmbH
Aegle Therapeutics Corp
Affibody AB
Allife Medical Science and Technology Co Ltd
Allosteros Therapeutics Inc
Amarantus Bioscience Holdings Inc
Anavex Life Sciences Corp
Ankasa Regenerative Therapeutics Inc
Annovis Bio Inc
AntiRadical Therapeutics LLC
Antoxis Ltd
Apellis Pharmaceuticals Inc
Aposcience AG
APT Therapeutics Inc
AptaTargets SL
Aranda Pharma Ltd
ArmaGen Inc
Aronora Inc
Artelo Biosciences Inc
ArunA Biomedical Inc
Asta Pharmaceuticals Co Ltd
AstraZeneca Plc
Athersys Inc
Avilex Pharma ApS
Axolo Pharma Inc
Band Therapeutics LLC
Beijing Yinfeng Dingcheng Bioengineering Co Ltd
BioAxone BioSciences Inc
Biogen Inc
Boehringer Ingelheim International GmbH
Brain-Gen LLC
Bristol-Myers Squibb Co
CardioVascular BioTherapeutics Inc
Celltrion Inc
Cenyx Biotech Inc
Cerebrum Therapeutics Inc
CHA Bio & Diostech Co Ltd
China Resources Emde Biological Pharmaceutical Co Ltd
Cogentis Therapeutics Inc
CohBar Inc
Constant Therapeutics LLC
CSPC Pharmaceutical Group Ltd
Curacle Co Ltd
CuroNZ Ltd
Daewoong Pharmaceutical Co Ltd
Daiichi Sankyo Co Ltd
Deha Pharmaceutical LLC
DiaMedica Therapeutics Inc
Diffusion Pharmaceuticals Inc
Edvince AB
EIP Pharma LLC
Epigen Biosciences Inc
Epygen Biotech Pvt Ltd
Ever Supreme Bio Technology Co Ltd
Evgen Pharma Plc
eXithera Pharmaceuticals Inc
Exscien Corp
F. Hoffmann-La Roche Ltd
Fortuna Fix Inc
Freeox Biotech SL
Fujifilm Toyama Chemical Co Ltd
GABA Therapeutics Inc
Genervon Biopharmaceuticals LLC
Glialogix Inc
Glucox Biotech AB
GNT Pharma Co Ltd
Guangzhou Cellprotek Pharmaceutical Co Ltd
Guangzhou Magpie Pharmaceutical Co Ltd
Guangzhou Recomgen Biotech Co Ltd
Guangzhou-Sheng Jian Chi Pharmaceutical Co Ltd
Gwoxi Stem Cell Applied Technology Co Ltd
Hefei Industrial Pharmaceutical Institute Co Ltd
Hibernaid Inc
Hillhurst Biopharmaceuticals Inc
Hope Biosciences LLC
HSRx Group
Immunwork Inc
Instituto Biomar SA
International Stem Cell Corp
JCR Pharmaceuticals Co Ltd
Jeil Pharmaceutical Co Ltd
Jiangsu Ouwei Pharmaceutical Co Ltd
JT Pharmaceuticals Inc
Kai Nuo Bio Sci Co Ltd
Kyoto Drug Discovery & Development Co Ltd
Les Laboratoires Servier SAS
Lineage Cell Therapeutics Inc
Living Cell Technologies Ltd
Lixte Biotechnology Holdings Inc
LTT Bio-Pharma Co Ltd
Lumosa Therapeutics Co Ltd
M et P Pharma AG
Mapreg SAS
Marizyme Inc
Meridigen Biotech Co Ltd
Mitoconix Bio Ltd
Modulation Therapeutics Inc
NC Medical Research Inc
NeoCytex Biopharma Inc
NeuExcell Therapeutics Inc
Neuraly Inc
Neuren Pharmaceuticals Ltd
NeurExo Sciences LLC
NeuroActiva Inc
Neurodon LLC
NeuroFix Therapeutics LLC
NeuroNascent Inc
NeurOp Inc
Neurotrope Bioscience Inc
New World Laboratories Inc
Nipro Corp
NoNO Inc
Novago Therapeutics AG
Novartis AG
NuvOx Pharma LLC
Nyrada Inc
Omniox Inc
Paracelsus Neuroscience I LLC
Park Active Molecules
Pharmagenesis Inc
PharmatrophiX Inc
Pharmazz Inc
Pharmicell Co Ltd
Phoenix Biotechnology Inc
PhytoHealth Corp
Prediction BioSciences SAS
Primary Peptides Inc
Q Therapeutics Inc
Regenera Pharma Ltd
Regeneron Pharmaceuticals Inc
RegeneRx Biopharmaceuticals Inc
ReNetX Bio
ReNeuron Group Plc
Rich Pharmaceuticals Inc
Rubicon Biotechnology Inc
Saje Pharma LLC
SanBio Inc
Saneron CCEL Therapeutics Inc
Saniona AB
Sansho Co Ltd
Savara Inc
Seneca Biopharma Inc
Sentan Pharma Inc
Shanghai Angecon Biotechnology Corp
Shanghai SIMR Biotech Co Ltd
Shin Poong Pharm Co Ltd
Shionogi & Co Ltd
Simcere Pharmaceutical Group
Stemedica Cell Technologies Inc
Stemetix Inc
Stream Biomedical Inc
SunBio Inc
Suzhou Pharmavan Cancer Research Center Co Ltd
TaiGen Biotechnology Co Ltd
Tasly Pharmaceutical Group Co Ltd
Techfields Pharma Co Ltd
Tenax Therapeutics Inc
The Cell Factory BVBA
TheraSource LLC
Theratome Bio Inc
Thrombolytic Science International LLC
TikoMed AB
TMS Co Ltd
Translational Sciences Inc
Valin Technologies Ltd
Vect-Horus SAS
Verseon Corp
Virogenomics BioDevelopment Inc
Virtici LLC
WhanIn Pharmaceutical Co Ltd
Xcelthera INC
Xonovo Inc
Yantai YenePharma Co Ltd
Zensun (Shanghai) Sci & Tech Co Ltd
Zhejiang Ausun Pharmaceutical Co Ltd
Zocere Inc
ZyVersa Therapeutics Inc
ZZ Biotech LLC

For queries regarding this report:

Contact Us:
Sales Desk
USA: +1-800-416-3124

Follow us on Social Media:

Ritesh Tiwari is the Founder of Research By Markets, a leading Market Research Reports Reseller trusted by Fortune listed companies for their requirements of Syndicated and Custom Market Research Reports. Ritesh has an overall experience of 18+ years in Recruitments, Sales and Operations. He has been associated with the Market Research industry for the past 7 years. He is an avid foodie as well as a huge football fan being a supporter of Manchester United (EPL) and FC Barcelona (La Liga). Get in touch with him via *Market Research News is a part of Research By Markets.